Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 69Breast 6Genitourinary 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Urogenital Neoplasms 1Prostatic Neoplasms 1Prostatic Diseases 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Gonadal Disorders 1Genital Neoplasms, Male 1Genital Neoplasms, Female 1Genital Diseases, Male 1Genital Diseases, Female 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Adnexal Diseases 1

Interventions

Cyclophosphamide 4sargramostim 3Psychiatric Rehabilitation 3Paclitaxel 3Flow Cytometry 3trametinib 2pertuzumab 2pembrolizumab 2dabrafenib 2Trastuzumab 2Specimen Handling 2Palliative Care 2Methylprednisolone 2Melphalan 2Magnetic Resonance Spectroscopy 2Immunologic Techniques 2Filgrastim 2Biopsy 2Azacitidine 2Analgesia 2Amifostine 2Alemtuzumab 2varlilumab 1ulixertinib 1trastuzumab biosimilar HLX02 1tanespimycin 1stenoparib 1sapanisertib 1ruxolitinib 1rucaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × niraparib × Other hematologic neoplasm × Clear all
NCT00749502 2013-07-25

A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8)

Tesaro, Inc.

Phase 1 Completed
113 enrolled
GenitourinaryGynecologicLymphoidOther hematologic neoplasm

Adnexal Diseases, Endocrine System Diseases, Endocrine Gland Neoplasms, Genital Diseases, Female, Genital Diseases, Male, Genital Neoplasms, Female, Genital Neoplasms, Male, Gonadal Disorders, Neoplasms, Ovarian Diseases, Ovarian Neoplasms, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡